Depomed Reports Second Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. BBIO
7. RCKT
8. NVDA
9. CRBU
10. GOOGL

Go back to Depomed Reports Second Quarter 2016 Financial Results

DepoMed (DEPO) PT Bumped to $19 at Piper Jaffray, Remains Sidelined

August 4, 2016 7:29 AM EDT

Piper Jaffray analyst David Amsellem bumped his price target on DepoMed Inc (NASDAQ: DEPO) to $19.00 (from $18.00) but maintained a Neutral rating.

Amsellem commented, "Depomed reported 2Q16 diluted EPS of $0.27 on revenue of $117M, compared to Street estimates of $0.25 and $118M, respectively. Notably, DEPO... More

Depomed (DEPO) Tops Q2 EPS by 2c

August 3, 2016 4:02 PM EDT

Depomed (NASDAQ: DEPO) reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $116.7 million versus the consensus estimate of $118.2 million.

For earnings history and earnings-related data on Depomed (DEPO) click here.

... More